LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Szadowski, Hailey"
  2. AU="Burns, J."

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Developmental Pb exposure increases AD risk via altered intracellular Ca

    Xie, Junkai / Wu, Shichen / Szadowski, Hailey / Min, Sehong / Yang, Yang / Bowman, Aaron B / Rochet, Jean-Christophe / Freeman, Jennifer L / Yuan, Chongli

    The Journal of biological chemistry

    2023  Volume 299, Issue 8, Page(s) 105023

    Abstract: Exposure to environmental chemicals such as lead (Pb) during vulnerable developmental periods can result in adverse health outcomes later in life. Human cohort studies have demonstrated associations between developmental Pb exposure and Alzheimer's ... ...

    Abstract Exposure to environmental chemicals such as lead (Pb) during vulnerable developmental periods can result in adverse health outcomes later in life. Human cohort studies have demonstrated associations between developmental Pb exposure and Alzheimer's disease (AD) onset in later life which were further corroborated by findings from animal studies. The molecular pathway linking developmental Pb exposure and increased AD risk, however, remains elusive. In this work, we used human iPSC-derived cortical neurons as a model system to study the effects of Pb exposure on AD-like pathogenesis in human cortical neurons. We exposed neural progenitor cells derived from human iPSC to 0, 15, and 50 ppb Pb for 48 h, removed Pb-containing medium, and further differentiated them into cortical neurons. Immunofluorescence, Western blotting, RNA-sequencing, ELISA, and FRET reporter cell lines were used to determine changes in AD-like pathogenesis in differentiated cortical neurons. Exposing neural progenitor cells to low-dose Pb, mimicking a developmental exposure, can result in altered neurite morphology. Differentiated neurons exhibit altered calcium homeostasis, synaptic plasticity, and epigenetic landscape along with elevated AD-like pathogenesis markers, including phosphorylated tau, tau aggregates, and Aβ42/40. Collectively, our findings provide an evidence base for Ca dysregulation caused by developmental Pb exposure as a plausible molecular mechanism accounting for increased AD risk in populations with developmental Pb exposure.
    MeSH term(s) Animals ; Humans ; Alzheimer Disease/genetics ; Alzheimer Disease/pathology ; Homeostasis ; Induced Pluripotent Stem Cells/pathology ; Lead/toxicity ; Neurons/pathology
    Chemical Substances Lead (2P299V784P)
    Language English
    Publishing date 2023-07-07
    Publishing country United States
    Document type Journal Article ; Research Support, U.S. Gov't, Non-P.H.S. ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 2997-x
    ISSN 1083-351X ; 0021-9258
    ISSN (online) 1083-351X
    ISSN 0021-9258
    DOI 10.1016/j.jbc.2023.105023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Compact engineered human mechanosensitive transactivation modules enable potent and versatile synthetic transcriptional control.

    Mahata, Barun / Cabrera, Alan / Brenner, Daniel A / Guerra-Resendez, Rosa Selenia / Li, Jing / Goell, Jacob / Wang, Kaiyuan / Guo, Yannie / Escobar, Mario / Parthasarathy, Abinand Krishna / Szadowski, Hailey / Bedford, Guy / Reed, Daniel R / Kim, Sunghwan / Hilton, Isaac B

    Nature methods

    2023  Volume 20, Issue 11, Page(s) 1716–1728

    Abstract: Engineered transactivation domains (TADs) combined with programmable DNA binding platforms have revolutionized synthetic transcriptional control. Despite recent progress in programmable CRISPR-Cas-based transactivation (CRISPRa) technologies, the TADs ... ...

    Abstract Engineered transactivation domains (TADs) combined with programmable DNA binding platforms have revolutionized synthetic transcriptional control. Despite recent progress in programmable CRISPR-Cas-based transactivation (CRISPRa) technologies, the TADs used in these systems often contain poorly tolerated elements and/or are prohibitively large for many applications. Here, we defined and optimized minimal TADs built from human mechanosensitive transcription factors. We used these components to construct potent and compact multipartite transactivation modules (MSN, NMS and eN3x9) and to build the CRISPR-dCas9 recruited enhanced activation module (CRISPR-DREAM) platform. We found that CRISPR-DREAM was specific and robust across mammalian cell types, and efficiently stimulated transcription from diverse regulatory loci. We also showed that MSN and NMS were portable across Type I, II and V CRISPR systems, transcription activator-like effectors and zinc finger proteins. Further, as proofs of concept, we used dCas9-NMS to efficiently reprogram human fibroblasts into induced pluripotent stem cells and demonstrated that mechanosensitive transcription factor TADs are efficacious and well tolerated in therapeutically important primary human cell types. Finally, we leveraged the compact and potent features of these engineered TADs to build dual and all-in-one CRISPRa AAV systems. Altogether, these compact human TADs, fusion modules and delivery architectures should be valuable for synthetic transcriptional control in biomedical applications.
    MeSH term(s) Animals ; Humans ; Transcriptional Activation ; CRISPR-Cas Systems ; Gene Expression Regulation ; Transcription Factors/genetics ; Transcription Factors/metabolism ; Fibroblasts/metabolism ; Mammals/metabolism
    Chemical Substances Transcription Factors
    Language English
    Publishing date 2023-10-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2169522-2
    ISSN 1548-7105 ; 1548-7091
    ISSN (online) 1548-7105
    ISSN 1548-7091
    DOI 10.1038/s41592-023-02036-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top